Correlation of metalloproteinase-2 and -9 with proinflammatory cytokines interleukin-1β, interleukin-12 and the interleukin-1 receptor antagonist in patients with chronic uveitis

被引:0
|
作者
El-Shabrawi, Y [1 ]
Christen, WG [1 ]
Foster, CS [1 ]
机构
[1] Massachusetts Eye & Ear Infirm, Immunol & Uveitis Serv, Boston, MA 02114 USA
关键词
uveitis; matrix metalloproteinases; interleukin-1; beta; interleukin-1 receptor antagonists; interleukin-12; proinflammatory cytokines; human;
D O I
10.1076/0271-3683(200003)20:3;1-9;FT211
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. Matrix metalloproteinases have been shown to play a role in active uveitis. Transcription of MMPs is induced by a number of growth factors and cytokines. This study investigates the role of MMPs in chronic uveitis and correlates the amounts of MMP-2 and -9 in intraocular samples to the intraocular levels of proinflammatory cytokines (Interleukin-1 [IL-1], Interleukin-12 [IL-12] and Interleukin-1 receptor antagonist [IL-1ra]). Methods. Aqueous humor of 16 patients was collected during surgical or diagnostic procedures (control group: cataract patients). MMP-2 and -9 were measured using zymography. IL-1, IL-12 and IL-1ra were evaluated by ELISA. Results. We found MMP-2 and -9 in all of our uveitis patients. In the control group only MMP-2 was seen. Higher levels of MMP-2 and -9 were found in patients with higher activity of uveitis (p < 0.014 for MMP-2, p < 0.0054 for MMP-9). The amounts of IL-1, IL-12 and IL-1ra detected in our uveitis patients correlated with levels of MMP-2 (p < 0.07, p < 0.0004, p < 0.03) and MMP-9 (p < 0.003, p < 0.0001, p < 0.002), and IL-12 (p < 0.004, p < 0.0001). Patients with moderately active uveitis presented with twice the level of MMP-2 as the control group; MMP-9 levels reached up to 92% of the amounts found in patients with active uveitis. Two patients in remission for almost one year still had detectable intraocular MMP-9 levels. Conclusion. Our data suggests that the high levels of MMPs found in patients with chronic uveitis might contribute to the damage often seen in these eyes. Since MMPs are capable of releasing proinflammatory cytokines bound to components of the extracellular matrix, and facilitate the secretion of active TNF-alpha by cleavage of the membrane bound form, it is conceivable that MMPs contribute to the chronicity of some uveitis cases.
引用
收藏
页码:211 / 214
页数:4
相关论文
共 50 条
  • [31] Interleukin-1, interleukin-1 receptor antagonist and macrophage populations in rheumatoid arthritis synovial membrane
    Cauli, A
    Yanni, G
    Panayi, GS
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (09): : 935 - 940
  • [32] Interleukin-11, interleukin-1β, interleukin-12 and the pathogenesis of inflammatory periodontal diseases
    Yucel, Ozlem Ozer
    Berker, Ezel
    Gariboglu, Semra
    Otlu, Harika
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2008, 35 (05) : 365 - 370
  • [33] Influence of interleukin-10 on the interleukin-1 receptor antagonist/interleukin-1β ratio in the colonic mucosa of ulcerative colitis
    Ishizuka, K
    Sugimura, K
    Homma, T
    Matsuzawa, J
    Mochizuki, T
    Kobayashi, M
    Suzuki, K
    Otsuka, K
    Tashiro, K
    Yamaguchi, O
    Asakura, H
    DIGESTION, 2001, 63 : 22 - 27
  • [34] Regulation of interleukin-1β by the interleukin-1 receptor antagonist in the glutamate-injured spinal cord:: Endogenous neuroprotection
    Liu, Song
    Xu, Guo-Ying
    Johnson, Kathia M.
    Echetebu, Clement
    Ye, Zaiming
    Hulsebosch, Claire E.
    McAdoo, David J.
    BRAIN RESEARCH, 2008, 1231 : 63 - 74
  • [35] Retinoic acid differentially regulates interleukin-1β and interleukin-1 receptor antagonist production by human alveolar macrophages
    Hashimoto, S
    Hayashi, S
    Yoshida, S
    Kujime, K
    Maruoka, S
    Matsumoto, K
    Gon, Y
    Koura, T
    Horie, T
    LEUKEMIA RESEARCH, 1998, 22 (11) : 1057 - 1061
  • [36] Specificity of interleukin-1β-induced changes in monoamine concentrations in hypothalamic nuclei:: Blockade by interleukin-1 receptor antagonist
    MohanKumar, SMJ
    MohanKumar, PS
    Quadri, SK
    BRAIN RESEARCH BULLETIN, 1998, 47 (01) : 29 - 34
  • [37] Induction of interleukin-1 beta and interleukin-1 receptor antagonist mRNA by chronic treatment with various psychotropics in widespread area of rat brain
    Suzuki, E
    Shintani, F
    Kanba, S
    Asai, M
    Nakaki, T
    NEUROSCIENCE LETTERS, 1996, 215 (03) : 201 - 204
  • [38] Physiologic role of interleukin-1 receptor antagonist
    William P Arend
    Cem Gabay
    Arthritis Research & Therapy, 2
  • [39] Physiologic role of interleukin-1 receptor antagonist
    Arend, WP
    Gabay, C
    ARTHRITIS RESEARCH, 2000, 2 (04) : 245 - 248
  • [40] Human endometrial stromal interleukin-1 beta: Autocrine secretion and inhibition by interleukin-1 receptor antagonist
    Tanaka, T
    Sakamoto, T
    Mizuno, K
    Umesaki, N
    Ogita, S
    HORMONE RESEARCH, 2000, 53 (06) : 300 - 304